Stock Taper
SCREENER COMPARE ANY 2 STOCKS
ALZN
ALZAMEND NEURO INC
NASDAQ
$1.66
▼ DOWN 0.30% (-0.01)

KEY STATISTICS

Market Cap$6.32 M
52w High$2.68
52w Low$0.84
Dividend Yield—
Frequency—
P/E-0.57
Volume242.12K
Shares Out.3.80M

COMPANY

LEADERSHIP

Stephan Jackman
CHIEF EXECUTIVE
Stephan Jackman

COMPENSATION 2026

Salary$350,000
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$18,288
Total$468,288

ABOUT

SECTOR
Healthcare
WENT PUBLIC
June 15, 2021
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
6

UPCOMING EARNINGS

DateSep 9, 2026
DayWednesday
Rev. Est.—
SEP
9
WED

SPLIT RECORD

DATETYPERATIO
2025-05-12Reverse1:9
2024-07-16Reverse1:10
2023-10-31Reverse1:15

PRICE

$1.66 ▼ DOWN 0.30% (−$0.01)
OVERLAYS
$1.65$1.68$1.70$1.729:43 AM10:46 AM11:48 AM12:51 PM1:54 PM2:56 PM3:59 PM1.66

About Alzamend Neuro Inc

https://www.alzamend.com ↗

Alzamend Neuro, Inc. is a clinical-stage biopharma developing treatments for neurodegenerative and psychiatric disorders, with products like AL001 in Phase II for conditions including Alzheimer's and bipolar disorder, and AL002 in preclinical stages.

INDUSTRY

Biotechnology

A PRODUCT ALZAMEND NEURO INC IS KNOWN FOR

AL001
AL001

AL001, Alzamend Neuro's lead clinical-stage ionic cocrystal of lithium, is in Phase II trials for treating Alzheimer's, Bipolar Disorder, Major Depressive Disorder, and PTSD, aiming for improved brain delivery and fewer side effects.

COMPETITORS

COMPETITOR
ACIU COMPARE
ALEC COMPARE
AVXL COMPARE
DNLI COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
1
LISTED HERE
1
RANKED BY POSITION SIZE
VXF
0.00% · 7.6K

RATINGS SNAPSHOT

Overall rating: C-

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book2
Overall Score1

INSIDER TRADES

★
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Jackman Stephan
Purchase · 450.0K shares
2026-04-17
★
DIRECTOR, OTHER: DIRECTOR BY DEPUTIZATION
Hyperscale Data, Inc.
Purchase · 7.5K shares
2026-07-31
★
DIRECTOR
Horne William B.
Purchase · 60.0K shares
2026-04-17
★
DIRECTOR, OTHER: DIRECTOR BY DEPUTIZATION
Hyperscale Data, Inc.
— · 988 shares
2022-04-26

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 1
1 GRADES IN THE LAST 12 MONTHS
Ascendiant Capital BUY

SECTORS PEERS

PEERPRICE
BCDA$1.15COMPARE
NRSN$0.42COMPARE
PHIO$1.13COMPARE
KPRX$2.62COMPARE
APRE$0.84COMPARE
ACXP$1.44COMPARE
CDIO$1.85COMPARE
ADIL$5.60COMPARE